PBYI - Puma Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PBYI is currently covered by 1 analysts with an average price target of $15.1. This is a potential upside of $9.4 (164.91%) from yesterday's end of day stock price of $5.7.

Puma Biotechnology's activity chart (see below) currently has 159 price targets and 104 ratings on display. The stock rating distribution of PBYI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.36% with an average time for these price targets to be met of 139.62 days.

Highest price target for PBYI is $4, Lowest price target is $4.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 02-Feb-2015.

Currently out of the existing stock ratings of PBYI, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Dec-2019

$7

$1.3 (22.81%)

$7

1 years 1 days ago
(28-Feb-2025)

10/17 (58.82%)

$3.42 (95.53%)

533

Hold Since 24-Jan-2018

$4

$-1.7 (-29.82%)

$7

2 years 3 months 26 days ago
(03-Nov-2023)

4/9 (44.44%)

$1.22 (43.88%)

92

Hold Since 05-Nov-2021

$7

$1.3 (22.81%)

$9

4 years 3 months 24 days ago
(05-Nov-2021)

4/5 (80%)

$2.99 (74.56%)

249

Sell Since 02-Nov-2018

$5

$-0.7 (-12.28%)

$6

4 years 3 months 24 days ago
(05-Nov-2021)

5/7 (71.43%)

$0.99 (24.69%)

261

Buy Since 27-Sep-2021

$11

$5.3 (92.98%)

$11

4 years 5 months 2 days ago
(27-Sep-2021)

11/24 (45.83%)

$3.88 (54.49%)

157

Show more analysts

Please expand the browser size to see the chart

What is PBYI (Puma Biotechnology) average time for price targets to be met?

On average it took 139.62 days on average for the stock forecasts to be realized with a an average price target met ratio 59.36

Which analyst has the current highest performing score on PBYI (Puma Biotechnology) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on PBYI (Puma Biotechnology)?

Yigal Nochomovitz works at CITI and has 30 price targets and 18 ratings on PBYI

Which analyst is the currently most bullish on PBYI (Puma Biotechnology)?

Thomas Shrader with highest potential upside - $124.3

Which analyst is the currently most reserved on PBYI (Puma Biotechnology)?

Chris Shibutani with lowest potential downside - -$1.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?